en

PRODUCT DETAIL

VANFLYTA 26,5 mg filmom obalené tablety

Code 5051E
MA number EU/1/23/1768/005
Product Form: tbl flm 56x1x26,5 mg (blis.Al/Al - jednotk.bal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX11 Quizartinib
Shelf life: 36
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 06.11.2023
Validity: 06.11.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.11.2023
eu-flag.png sk-flag.png